Telomir Pharmaceuticals TELO Institutional Ownership

Ownership Summary

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) has 27 institutional investors that have filed 13F reports for the period ending March 2026.

• These investors held 7.1% of outstanding shares in March 2026, down from 7.5% in December 2025.
• They increased total shares held in TELO by 89.44% quarter over quarter, and investors in Telomir Pharmaceuticals decreased 37.21% from a year ago.
• Among the 27 funds, 9 bought more Telomir Pharmaceuticals shares, 5 sold down, and 13 held their ground.
• Institutional investors collectively held 2.24Mn shares in Telomir Pharmaceuticals as of March 2026, up by 1.06Mn shares quarter on quarter, and down 1.61Mn shares year over year.
• As of March 31, 2026, the biggest holder of Telomir Pharmaceuticals is VANGUARD CAPITAL MANAGEMENT LLC at 995.37K shares, representing 3.14% of shares outstanding.
• The largest buyers of Telomir Pharmaceuticals for the quarter ending March 2026 were VANGUARD CAPITAL MANAGEMENT LLC (995.37K), VANGUARD FIDUCIARY TRUST CO (135.54K), GEODE CAPITAL MANAGEMENT, LLC (25.54K), Goldman Sachs Group Inc (10.41K), Praetorian Wealth Management, Inc. (10.0K).
• The largest sales of TELO for the quarter ending March 2026 came from Suncoast Equity Management (51.19K), MILLENNIUM MANAGEMENT LLC (37.92K), World Investment Advisors (33.84K), UBS Group AG (4.84K), XTX Topco Ltd (3.65K).
• Per Business Quant data, the top 10 holders of Telomir Pharmaceuticals for the quarter ending March 2026 are VANGUARD CAPITAL MANAGEMENT LLC (995.37K), BlackRock, Inc. (289.2K), GEODE CAPITAL MANAGEMENT, LLC (249.09K), VANGUARD FIDUCIARY TRUST CO (135.54K), MILLENNIUM MANAGEMENT LLC (129.06K), State Street Corp (58.6K), Bank of New York Mellon Corp (51.45K), Suncoast Equity Management (51.19K), Northern Trust Corp (41.84K), World Investment Advisors (37.04K).